CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Inmune Bio, Inc.

For profitWebsite ↗

Also known as: INmune Bio | Inmune Bio, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Nov 30, 2023

Timeline

2010s

Jun 1, 2015
Inmune Bio, Inc.— Founded

Drugs by trial phase (2 distinct, 7 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Alzheimer Disease

Recent trials (12)

NCT06056791Lead sponsorPhase 1/Phase 2Nov 30, 2023
NCT06056791Study directorPhase 1/Phase 2Nov 30, 2023
NCT05522387Lead sponsorPhase 2Nov 30, 2022
NCT05522387Study directorPhase 2Nov 30, 2022
NCT05321498Lead sponsorPhase 2Sep 30, 2022
NCT05321498Study directorPhase 2Sep 30, 2022
NCT05318976Lead sponsorPhase 2Feb 28, 2022
NCT05318976Study directorPhase 2Feb 28, 2022
NCT04370236Lead sponsorPhase 2Jun 30, 2020
NCT05933070Study directorPhase 1Jun 15, 2020
NCT05933070Lead sponsorPhase 1Jun 15, 2020
NCT03943264Lead sponsorPhase 1Jun 30, 2019

Details

Founded: La Jolla, CA, US Jun 1, 2015
Last known activity: Nov 30, 2023